We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Events

27 Jan 2025 - 30 Jan 2025
15 Feb 2025 - 17 Feb 2025

Blood Processor Blocks DNA Replication, Making Platelets Safer

By HospiMedica International staff writers
Posted on 31 Aug 2009
Print article
A blood product processing system uses a psoralen molecule for effective pathogen inactivation, thus controlling the safety of platelets and plasma in blood centers and hospital blood banks.

The Intercept blood system offers inactivation for a broad range of viruses (both enveloped and non-enveloped), bacteria, and protozoa (intracellular and extracellular), as well as leukocytes. The system employs the unique properties of a specially developed molecule, amotosalen HCl, to block irreversibly the replication of DNA and RNA, preventing the proliferation of susceptible pathogens. The interaction of amotosalen with DNA and RNA is highly specific and occurs with high frequency even at low concentrations of nucleic acids. Once inside a pathogen, amotosalen docks in between the nucleic acid base pairs; upon illumination with ultraviolet A (UVA) light, an interstrand crosslink is formed, "locking” the DNA or RNA together so that it can no longer replicate; the reaction requires UVA light and will not continue in its absence. The platelets and plasma are not inactivated by the crosslinking process, since they do not require nucleic acids for their therapeutic functions. Prior to transfusion of the stored blood products, a removal process reduces residual amotosalen to trace levels.

The system uses one illumination device for treating both plasma and platelets, with the same process and same active compound; it is designed for high throughput, capable of processing of up to 36 plasma units per hour per UVA illuminator, with a total of less than 10 minutes total hands-on time. Synergy with the platelet treatment further improves efficiency for blood centers performing both processes, allowing over 20 combined units per hour of platelets and plasma from whole blood and apheresis collections. The Intercept blood system is a product of Cerus (Concord, CA, USA).

"We commend the Belgian government on its leadership within the field of transfusion safety, which now includes becoming the first country to require pathogen inactivation of both platelets and plasma for transfusion,” said Dr. Laurence Corash, senior vice president and chief medical officer of Cerus, commenting on a Belgian Royal Decree issued mandating universal use of pathogen inactivation for platelets no later than August 2010. The Intercept blood system has been used in Belgium since 2003 for treatment of platelets, and since 2007 for treatment of plasma.

Amotosalen belongs to a group of photoactive compounds called psoralens, which possess a characteristic three-ring fused structure. Naturally occurring psoralens can be found in a variety of plants and foods such as limes, celery, and parsnips. Reports of the medicinal use of psoralens to treat vitiligo and psoriasis in India date back to about 1400 BC.

Related Links:

Cerus


New
Gold Member
X-Ray QA Meter
T3 AD Pro
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
In-Bed Scale
IBFL500
New
Blanket Warming Cabinet
EC250

Print article

Channels

Surgical Techniques

view channel
Image: Schematic diagram of intra-articular pressure detection using a sensory system in a sheep model (Photo courtesy of Science China Press)

Novel Sensory System Enables Real-Time Intra-Articular Pressure Monitoring

Knee replacement surgery is a widely performed procedure to relieve knee pain and restore joint function, with over one million surgeries conducted annually. However, 10%-20% of patients remain dissatisfied... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.